ICD-10-CM Billable Code

R82.0

Chyluria

Clinical Classification Guidelines

Excludes Type 1

  • filarial chyluria (B74.-)

Medical Intelligence & Overview

Chyluria is a medical condition characterized by the presence of chyle – a milky bodily fluid consisting of lymph and fats – in the urine. This condition results in urine that appears cloudy or milky, which can cause concern and discomfort. Chyluria is often a sign of an underlying issue with the lymphatic system or kidneys. While it is more common in certain regions of the world, awareness of its causes, symptoms, and potential treatments can help individuals seek appropriate medical care.

Causes & Symptoms

Clinical Causes: Filariasis (a parasitic infection caused by Wuchereria bancrofti or Brugia malayi), which damages lymphatic vessels Lymphatic malformations or congenital abnormalities that disrupt normal lymph flow Obstructions or injuries to the lymphatic or urinary systems due to trauma or surgical procedures Tumors or cancer affecting the lymphatic channels or kidneys Inflammatory or infectious diseases impacting the lymphatic pathways

Key Symptoms: Milky or cloudy urine, often persistent Urinary urgency or frequency Lower abdominal or flank pain Swelling or edema in the groin, legs, or genital area (in some cases) Possible hematuria (blood in urine) Recurrent urinary tract infections

Diagnostic & Treatment

Diagnosis Path: Diagnosis of chyluria involves a combination of clinical observation and laboratory tests. Common diagnostic methods include: - **Urinalysis**: Detects the presence of chyle components, such as fats and lymphocytes, contributing to the milky appearance. - **Sudan III or Oil Red O stain**: Specialized stains that help visualize fats within the urine. - **Lymphangiography**: Imaging technique to visualize lymphatic vessels and identify abnormal connections or obstructions. - **Blood tests**: To check for parasitic infections, especially in endemic regions. - **Ultrasound or CT scans**: Used to evaluate the kidneys and surrounding structures for abnormalities or tumors. A comprehensive assessment helps determine the underlying cause and appropriate treatment options.

Treatment Protocols: Managing chyluria depends on its underlying cause. Treatment approaches include: - **Medical Management**: - Antiparasitic medications if filariasis is identified - Dietary modifications such as a low-fat, high-protein diet to reduce chyle production - Use of anti-inflammatory drugs to mitigate lymphatic inflammation - **Interventional Procedures**: - Sclerotherapy, where a sclerosant agent is injected to seal abnormal lymphatic connections - Lymphatic vessel embolization in cases involving lymphatic leakage - **Surgical Options**: - Lymphatic duct ligation or lymphatic-venous shunt to redirect lymph flow - Removal of obstructing tumors or lymphatic malformations The choice of treatment varies based on severity, underlying cause, and patient health. Long-term follow-up is essential to monitor for recurrence and manage any ongoing symptoms.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is R82.0 a billable ICD-10 code?
Yes, R82.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report R82.0?
Clinical documentation must specify the nature of Chyluria and any associated comorbidities for accurate reporting.

Cite this Clinical Reference